Pair Name | Cepharanthine, Cisplatin | ||
Phytochemical Name | Cepharanthine (PubChem CID: 10206 ) | ||
Anticancer drug Name | Cisplatin (PubChem CID: 5702198 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Cepharanthine, Cisplatin | |||
Disease Info | [ICD-11: 2B70] | Esophageal cancer | Investigative | |
Biological Phenomena | Induction-->Blockade of cell cycle in G2/M phase | |||
Gene Regulation | Down-regulation | Expression | ABCB1 | hsa5243 |
Up-regulation | Expression | APAF1 | hsa317 | |
Up-regulation | Expression | BAX | hsa581 | |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Up-regulation | Expression | CDKN1A | hsa1026 | |
Up-regulation | Expression | CYCS | hsa54205 | |
Up-regulation | Phosphorylation | JUN | hsa3725 | |
Up-regulation | Phosphorylation | MAPK8 | hsa5599 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Up-regulation | Expression | TP53 | hsa7157 | |
In Vitro Model | Eca-109 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_6898 |
In Vivo Model | Eca109 (3×10⁶) and Eca109/CDDP cells were injected subcutaneously (s.c.) into the flanks of mice. | |||
Result | Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals |
No. | Title | Href |
---|---|---|
1 | Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals. Oncotarget. 2017 Nov 27;8(67):111144-111160. doi: 10.18632/oncotarget.22676. | Click |